Racial Disparities Among Patients with Lung Cancer Who Were Recommended Operative Therapy

Overview

Journal Arch Surg

Publisher American Medical Association

Specialty General Surgery

Date 2009 Jan 21

PMID 19153319

Citations 50

Authors

Farhood Farjah

Douglas E Wood

N David Yanez 3rd

Thomas L Vaughan

Rebecca Gaston Symons

Bahirathan Krishnadasan

David R Flum

Affiliations

Soon will be listed here.

Abstract

Hypothesis: Health care system and provider biases and differences in patient characteristics are thought to be prevailing factors underlying racial disparities. The influence of these factors on the receipt of care would likely be mitigated among patients who are recommended optimal therapy. We hypothesized that there would be no significant evidence of racial disparities among patients with early-stage lung cancer who are recommended surgical therapy.

Design, Setting, And Patients: Retrospective cohort study of patients in the Surveillance, Epidemiology, and End Results-Medicare database who were diagnosed with stage I or II lung cancer between January 1, 1992, and December 31, 2002 (follow-up through December 31, 2005).

Main Outcome Measures: Receipt of lung resection and overall survival.

Results: Among 17,739 patients who were recommended surgical therapy (mean [SD] age, 75 [5] years; 89% white, 6% black), black patients less frequently underwent resection compared with white patients (69% vs 83%, respectively; P < .001). After adjustment, black race was associated with lower odds of receiving surgical therapy (odds ratio = 0.43; 99% confidence interval, 0.36-0.52). Unadjusted 5-year survival rates were lower for black patients compared with white patients (36% vs 42%, respectively; P < .001). After adjustment, there was no significant association between race and death (hazard ratio = 1.03; 99% confidence interval, 0.92-1.14) despite a 14% difference in receipt of optimal therapy.

Conclusions: Even among patients who were recommended surgical therapy, black patients underwent lung resection less often than white patients. Unexpectedly, racial differences in the receipt of optimal therapy did not appear to affect outcomes. These findings suggest that distrust, beliefs and perceptions about lung cancer and its treatment, and limited access to care (despite insurance) might have a more dominant role in perpetuating racial disparities than previously recognized.

Citing Articles

Mediators of Racial Inequities in Non-Small Cell Lung Cancer Care.

Hamid S, Lee D, Herrin J, Yu J, Pollack C, Dean L Cancer Med. 2025; 14(5):e70757.

PMID: 40052387 PMC: 11886416. DOI: 10.1002/cam4.70757.

Variation in Long-Term Postoperative Mortality Risk by Race/Ethnicity After Major Non-cardiac Surgeries in the Veterans Health Administration.

Sharath S, Balentine C, Berger D, Zhan M, Zamani N, Choi J J Racial Ethn Health Disparities. 2024; .

PMID: 39264540 DOI: 10.1007/s40615-024-02176-w.

Evaluating the Impact of Race-Neutral Interpretation of Preoperative Pulmonary Function.

Steiling K Ann Am Thorac Soc. 2023; 21(1):32-34.

PMID: 38156898 PMC: 10867907. DOI: 10.1513/AnnalsATS.202309-834ED.

What health inequalities exist in access to, outcomes from and experience of treatment for lung cancer? A scoping review.

Lennox L, Lambe K, Hindocha C, Coronini-Cronberg S BMJ Open. 2023; 13(11):e077610.

PMID: 37918927 PMC: 10626811. DOI: 10.1136/bmjopen-2023-077610.

Delays to surgery and worse outcomes: The compounding effects of social determinants of health in non-small cell lung cancer.

Ashrafi A, Ding L, Atay S, Wightman S, Harano T, Kim A JTCVS Open. 2023; 15:468-478.

PMID: 37808033 PMC: 10556947. DOI: 10.1016/j.xjon.2023.05.015.

References

. Non-small cell lung cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2009; 2(2):94-123. DOI: 10.6004/jnccn.2004.0010. View

Scott W, Howington J, Movsas B . Treatment of stage II non-small cell lung cancer. Chest. 2003; 123(1 Suppl):188S-201S. DOI: 10.1378/chest.123.1_suppl.188s. View

Bach P . Racial disparities and site of care. Ethn Dis. 2005; 15(2 Suppl 2):S31-3. View

Warren J, Klabunde C, Schrag D, Bach P, Riley G . Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002; 40(8 Suppl):IV-3-18. DOI: 10.1097/01.MLR.0000020942.47004.03. View

Gordon H, Street Jr R, Sharf B, Souchek J . Racial differences in doctors' information-giving and patients' participation. Cancer. 2006; 107(6):1313-20. DOI: 10.1002/cncr.22122. View

Jazieh A, Kyasa M, Sethuraman G, Howington J . Disparities in surgical resection of early-stage non-small cell lung cancer. J Thorac Cardiovasc Surg. 2002; 123(6):1173-6. DOI: 10.1067/mtc.2002.122538. View

Klabunde C, Potosky A, Legler J, Warren J . Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2001; 53(12):1258-67. DOI: 10.1016/s0895-4356(00)00256-0. View

Gordon H, Street Jr R, Sharf B, Kelly P, Souchek J . Racial differences in trust and lung cancer patients' perceptions of physician communication. J Clin Oncol. 2006; 24(6):904-9. DOI: 10.1200/JCO.2005.03.1955. View

Shavers V, Brown M . Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002; 94(5):334-57. DOI: 10.1093/jnci/94.5.334. View

10.

Virnig B, Warren J, Cooper G, Klabunde C, Schussler N, Freeman J . Studying radiation therapy using SEER-Medicare-linked data. Med Care. 2002; 40(8 Suppl):IV-49-54. DOI: 10.1097/00005650-200208001-00007. View

11.

Bach P, Pham H, Schrag D, Tate R, Hargraves J . Primary care physicians who treat blacks and whites. N Engl J Med. 2004; 351(6):575-84. DOI: 10.1056/NEJMsa040609. View

12.

Klabunde C, Warren J, Legler J . Assessing comorbidity using claims data: an overview. Med Care. 2002; 40(8 Suppl):IV-26-35. DOI: 10.1097/00005650-200208001-00004. View

13.

Cykert S, Phifer N . Surgical decisions for early stage, non-small cell lung cancer: which racially sensitive perceptions of cancer are likely to explain racial variation in surgery?. Med Decis Making. 2003; 23(2):167-76. DOI: 10.1177/0272989X03251244. View

14.

Margolis M, Christie J, Silvestri G, Kaiser L, Santiago S, Hansen-Flaschen J . Racial differences pertaining to a belief about lung cancer surgery: results of a multicenter survey. Ann Intern Med. 2003; 139(7):558-63. DOI: 10.7326/0003-4819-139-7-200310070-00007. View

15.

Wisnivesky J, McGinn T, Henschke C, Hebert P, Iannuzzi M, Halm E . Ethnic disparities in the treatment of stage I non-small cell lung cancer. Am J Respir Crit Care Med. 2005; 171(10):1158-63. DOI: 10.1164/rccm.200411-1475OC. View

16.

Bach P, Cramer L, Warren J, Begg C . Racial differences in the treatment of early-stage lung cancer. N Engl J Med. 1999; 341(16):1198-205. DOI: 10.1056/NEJM199910143411606. View

17.

Bach P, Guadagnoli E, Schrag D, Schussler N, Warren J . Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations. Med Care. 2002; 40(8 Suppl):IV-19-25. DOI: 10.1097/00005650-200208001-00003. View

18.

Epstein A, Ayanian J, Keogh J, Noonan S, Armistead N, Cleary P . Racial disparities in access to renal transplantation--clinically appropriate or due to underuse or overuse?. N Engl J Med. 2000; 343(21):1537-44, 2 p preceding 1537. PMC: 4598055. DOI: 10.1056/NEJM200011233432106. View

19.

Little A, Greer Gay E, Gaspar L, Stewart A . National survey of non-small cell lung cancer in the United States: epidemiology, pathology and patterns of care. Lung Cancer. 2007; 57(3):253-60. DOI: 10.1016/j.lungcan.2007.03.012. View

20.

Cooper G, Virnig B, Klabunde C, Schussler N, Freeman J, Warren J . Use of SEER-Medicare data for measuring cancer surgery. Med Care. 2002; 40(8 Suppl):IV-43-8. DOI: 10.1097/00005650-200208001-00006. View